Bone Biologics Corp - Warrants (13/10/2026

(Warrants)
NAS:BBLGW (USA)   Warrants (13/10/2026)
$ 41.62 +8.12 (+24.24%) 02:25 PM EST
At Loss
P/B:
0.45
Volume:
1.09K
Avg Vol (2M):
-
Volume:
1.09K
At Loss
Avg Vol (2M):
-
PE Ratio PS Ratio PB Ratio Price-to-FCF Market Cap
Current and historical daily PE Ratio for Bone Biologics Corp ( ) from 2021 to Jun 06 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Bone Biologics stock (BBLGW) PE ratio as of Jun 06 2024 is 0. More Details

Bone Biologics Corp (BBLGW) PE Ratio (TTM) Chart

To

Bone Biologics Corp (BBLGW) PE Ratio (TTM) Historical Data

Total 0
  • 1
Bone Biologics PE Ratio (TTM) Historical Data
Date PE Ratio (TTM) Data Date PE Ratio (TTM) Data

Bone Biologics Corp (BBLGW) PE Ratio (TTM) Comparison

Company Market Cap(Mil) PE Ratio (TTM)

Business Description

Business Description

Bone Biologics Corp
NAICS : 325412 SIC : 3842

Share Class Description:

BBLGW: Warrants (13/10/2026)
Description
Bone Biologics Corp is a healthcare solutions provider based in the United States. As a biotechnology firm, it engages its efforts in developing therapeutics to aid bone regeneration. The company's portfolio comprises its lead product, NELL-1, which is a bone void filler. Bone Biologics' technology has applications in the surgical specialties of spinal, orthopedic, general orthopedic, plastic reconstruction, neurosurgery, interventional radiology, and sports medicine.